國家衛生研究院 NHRI:Item 3990099045/4471
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 907165      Online Users : 883
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/4471


    Title: Leptin changes in Taiwanese girls with central precocious puberty before and during the GnRH agonist treatment
    Other Titles: 早熟女性病童在使用性釋素同族素治療前後瘦素之變化
    Authors: Su, PH;Wang, SL;Lin, CY;Chen, JY;Changlai, CP;Jian, SH;Chen, SJ
    Contributors: Division of Environmental Health and Occupational Medicine;Division of Biostatistics and Bioinformatics
    Abstract: To examine the relationship between leptin serum levels and pubertal development in girls with progressive central precocious puberty. We longitudinally investigated the leptin levels of 37 girls with central precocious puberty before and during treatment with the gonadotropin-releasing hormone agonist depot (leuprorelin acetate). Leptin and other hormone levels were determined by radioimmunoassay. Girls with central precocious puberty before treatment showed no significant difference in leptin levels as compared to the puberty stage at diagnosis of disease. In addition, the changes in leptin concentrations of girls with central precocious puberty during treatment were not statistically significant. In the Spearman correlation analysis of leptin levels with body mass index, bone age, chronological age, clinical pubertal signs along with luteinizing, follicle-stimulating, and estradiol hormone levels, we found that body mass index, weight, and chronological age were significantly correlated with leptin levels (p < 0.05) at both 3 and 6 months of leuprorelin treatment. Leptin levels increased with body mass index; however, this trend did not reach statistical significance at all follow-up time points. These data demonstrated that treatment with depot gonadotropin- releasing hormone agonist does not influence leptin concentrations. Serum leptin levels in patients with central precocious puberty are associated with body weight and body mass index.
    Date: 2005-09
    Relation: Acta Paediatrica Taiwanica. 2005 Sep;46(5):278-283,330.
    Link to: http://www.airitilibrary.com/searchdetail.aspx?DocIDs=16088115-200510-46-5-278-283-a
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=33644947912
    Appears in Collections:[Shu-Li Wang] Periodical Articles
    [Chin-Yu Lin(2002-2003)] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    SCP33644947912.pdf229KbAdobe PDF536View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback